Ketamine Hydrochloride 43066-0177-05
- Manufacturer
- Baxter Healthcare Corporation
- Dosage Form
- Injection
- Route
- Intramuscular And Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- September 17, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA219684
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ketamine Hydrochloride | 10 mg/mL |
Drug Class
General Anesthesia [PE]General Anesthetic [EPC]
Selected Package
43066-0177-05Selected5 CARTON in 1 CARTON (43066-177-05) / 1 SYRINGE, PLASTIC in 1 CARTON (43066-177-01) / 10 mL in 1 SYRINGE, PLASTIC